1. The CD26/DPP4-inhibitor vildagliptin suppresses lung cancer growth via macrophage-mediated NK cell activity. (29th January 2019) Authors: Jang, Jae-Hwi; Janker, Florian; De Meester, Ingrid; Arni, Stephan; Borgeaud, Nathalie; Yamada, Yoshito; Gil Bazo, Ignacio; Weder, Walter; Jungraithmayr, Wolfgang Journal: Carcinogenesis Issue: Volume 40:Number 2(2019) Page Start: 324 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗